As-needed administration of tricyclic and other non-SRI antidepressant drugs to treat premature ejaculation
AssigneeVivus, Inc.
InventorsPeter Tam, Neil Gesundheit, Leland F. Wilson
Life of this patent
Estimating the term…
Abstract
A method is provided for treatment of premature ejaculation by administration of an antidepressant drug selected from tricyclic antidepressants, tetracyclic antidepressants, MAO inhibitors, azaspirone antidepressants, and atypical non-SRI antidepressants. In a preferred embodiment, administration is on as “as-needed” basis, i.e., the drug is administered immediately or at most several hours prior to sexual activity. Pharmaceutical formulations and packaged kits are also provided.
Claims72
A method for treating premature ejaculation, which comprises administering to a male individual in need of such treatment, on an as-needed basis, a therapeutically effective amount of an antidepressant drug selected from the group consisting of tricyclic antidepressants, tetracyclic antidepressants, monoamine oxidase inhibitors, azaspirone antidepressants, and atypical non-SRI antidepressants.
A pharmaceutical formulation for treating premature ejaculation, comprising a rapid release formulation of a therapeutically effective amount of an antidepressant drug selected from the group consisting of tricyclic antidepressants, tetracyclic antidepressants, MAO inhibitors, azaspirone antidepressants, and atypical non-SRI antidepressants, and a pharmaceutically acceptable carrier.
A packaged kit for a patient to use in the treatment of premature ejaculation, comprising:
- a pharmaceutical formulation of an antidepressant drug selected from the group consisting of tricyclic antidepressants, tetracyclic antidepressants, MAO inhibitors, azaspirone antidepressants, and atypical non-SRI antidepressants;
- a container housing the pharmaceutical formulation during storage and prior to administration;
- and instructions for carrying out drug administration in a manner effective to treat premature ejaculation.
Dependencies are inferred from the claim text.